How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action

Medical Hypotheses

Volumn 46, Issue 3, 1996, Pages 295-302

  Novick, S G ^a   Godfrey, J C ^b   Godfrey, N J ^b   Wilder, H R ^c  

^a HOFSTRA UNIVERSITY   (United States)

^b Godfrey Science and Design Inc   (United States)

^c ST JOHN FISHER COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC;

ARTICLE; COMMON COLD; DISEASE COURSE; DRUG EFFECT; HUMAN; PRIORITY JOURNAL; ZINC METABOLISM;

HUMAN RHINOVIRUS 14; RHINOVIRUS;

EID: 0029936414     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90259-5     Document Type: Article

References (29)

1. Eby G A, Davis D R, Halcomb W W. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother 1984; 25: 20-24.
2. Couch R B. The common cold. J Infect Dis 1984; 150: 167-173.
3. Farr B M, Conner E M, Betts R F, Oleske J, Minnefor A, Gwaltney J M Jr. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987; 31: 1183-1187.
4. Douglas R M, Miles H B, Moore B W, Ryan P, Pinnock C B. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob Agents Chemother 1987; 31: 1263-1265.
5. Smith D S, Helzner E C, Nuttall C E J et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother 1989; 33: 646-648.
6. Godfrey J C. Zinc for the common cold. Antimicrob Agents Chemother 1988; 32: 605-606.
7. Godfrey J C, Conant-Sloane B, Smith D S, Turco J H, Mercer N, Godfrey N. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res 1992; 20: 234-246.
8. Korant B D, Kauer J C, Butterworth B E. Zinc ions inhibit replication of rhinoviruses. Nature 1974; 248: 588-590.
9. Korant B D, Butterworth B E. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. J Virol 1976; 18: 298-306.
10. Rahway N J. The Merck Manual of Diagnosis and Therapy, 15th edn. Merck, Sharpe & Dohme Research Laboratories Division of Merck & Co. Inc., 1987: 304-306.
11. Rahway N J. The Merck Manual of Diagnosis and Therapy, 15th edn. Merck, Sharpe & Dohme Laboratories Division of Merck & Co. Inc., 1987: 2530.
12. Al-Nakib W, Higgins P C, Barrow I, Batstone G, Tyrell D A. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 1987; 20: 893-901.
13. Zarembo J E, Godfrey J C, Godfrey N. Zinc (II) in saliva: determination of concentrations produced by several different formulations of zinc gluconate lozenges containing common excipients. J Pharm Sci 1992; 81: 128-130.
14. Godfrey J C, Conant-Sloane B, Turco J H, Mercer N, Godfrey N, Smith D S. Zinc and common cold: positive findings in a controlled study of a new formulation. Chicago: ICAAC, 1991: Abstract no. 1381.
15. Rhodes D, Klug A. Zinc fingers. Sci Am 1993; (February): 56-65.
16. Oelschlegel F J Jr, Brewer G J. Absorption of pharmacological doses of zinc. In: Zinc Metabolism: Current Aspects in Health and Disease. New York: Alan R Liss, Inc., 1977: 299-311.
17. Circla A M, Pisati G, Ratti R. Biological evaluation of zinc retention. Normal values in adult subjects. Med Lav 1980; 3: 244-250.
18. Spence M. Human Anatomy and Physiology. Menlo Park, CA: Benjamin Cummings Pub. Co., 1983: Ch. 13.
19. Travis J. Biotech gets a grip on cell adhesion. Science 1993; 260: 906-908.
20. Moffat A S. Going back to the future with small synthetic compounds. Science 1993; 260: 910-912.
21. Rosmann M G, Arnold E, Erickson J W et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 1985; 317: 145-153.
22. Olson N H, Kolatkar P R, Oliviera M A et al. Structure of a human rhinovirus complexed with its receptor molecule. Proc Nat Acad Sci 1993; 90: 507-511.
23. Tomassini J E, Maxson T R, Colonno R J. J Biol Chem 1989; 264: 1656-1662.
24. Lentz T L. In: Wegner C D, ed. Adhesion Molecules. New York, NY: Academic Press, 1994: 234.
25. Staunton D E, Merluzzi V J, Rothlein R, Barton R, Marlin S D, Springer T A. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989; 56: 849-853.
26. Staunton D E, Dustin M L, Erickson H P, Springer T A. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990; 61:243-254.
27. Meuer S C. In: Wegner C D, ed. Adhesion Molecules. New York, NY: Academic Press, 1994: 16.
28. Colonno R J, Condra J H, Mizutani S, Callahan P L, Davies M E, Murcko M A. Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc Natl Acad Sci USA 1988; 85: 5449-5453.
29. Gwaltney J M Jr. 96. Rhinovirus. In: Mandel G L, Douglas R G, Bennet J E, eds. Principles and Practice of Infectious Diseases. New York, NY: John Wiley & Sons, Inc., 1979: 1124-1134.